Company intelligence / Profile preview

Aquyre Biosciences

Weston, Massachusetts, United Statesaquyre.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aquyre Biosciences has developed and commercialized the CelTivity system, which enables real-time, two-minute assessment of lung biopsy sample adequacy using proprietary optical imaging. The system does not alter the tissue sample and provides immediate feedback to proceduralists. Over 500 procedures have been performed with successful adoption at major U.S. hospital systems.

Therapeutic areas: OncologyImmunologyHematology
Modalities: DeviceNon-pharmacological therapy
Industry: Pathology

Partnerships

Noah MedicalUPMC HamotJohn Muir HealthChristianaCare

Beyond the preview

Go deeper on Aquyre Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquyre Biosciences.

Explore the full profile